Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Adherence to Cholesterol Therapies and Identification of Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease

NCT06897566 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06897566
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06897566 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Adherence to Cholesterol Therapies and Identification of Barriers to Optimal LDL-C Targets in Patients With Atherosclerotic Cardiovascular Disease
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
September 21, 2024
Completion date
November 1, 2025
Enrollment
1,000 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, ldl level, statin adverse reaction